Clinical Trial Update: Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing two albiglutide drug products in healthy adult subjects to assess similarity in pharmacokinetic profiles.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Albiglutide product A (albiglutide)
• Albiglutide product B (albiglutide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED